Effects of Creatine Formulations on Exercise and Cognitive Performance
Effects of Creatine Monohydrate Versus a Multi-Ingredient Creatine Formulation on Exercise Performance, Cognitive Function, Hydration, and Gastrointestinal Tolerability
This study will examine whether a multi-ingredient creatine supplement produces different effects on exercise performance, cognitive function, hydration, and gastrointestinal symptoms compared with creatine monohydrate alone.
Approximately 16 healthy, physically active adults aged 18-40 years will participate. Each participant will take creatine monohydrate (5 grams per day) for 18 days and a multi-ingredient supplement containing creatine monohydrate (5 grams), sodium, potassium, magnesium, and taurine for another 18 days. The order of supplementation will be randomly assigned, with a 30-day break between conditions.
Participants will complete laboratory testing before and after each supplementation period. Testing will include bench press exercise to assess muscular endurance, repeated high-intensity cycling tests to assess exercise performance, and a computerized cognitive task to measure attention and reaction time. Researchers will also assess hydration, selected blood markers, perceived exertion, and gastrointestinal symptoms.
The findings may help determine whether adding electrolytes and taurine to creatine provides additional benefits or produces different physiological responses compared with creatine monohydrate alone.
A tanulmány áttekintése
Állapot
Állapot
Körülmények
Körülmények
Beavatkozás / kezelés
Beavatkozás / kezelés
Tanulmány típusa
Tanulmány típusa
Beiratkozás (Becsült)
Beiratkozás
Fázis
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
Tanulmányi kapcsolat
- Név: Terence A Moriarty
- Telefonszám: 319-273-6866
- E-mail: terence.moriarty@uni.edu
Tanulmányi helyek
-
-
Iowa
-
Cedar Falls, Iowa, Egyesült Államok, 50614
- Toborzás
- Wellness and Recreation Center
-
Kapcsolatba lépni:
- Terence A Moriarty
- Telefonszám: 319-273-6866
- E-mail: terence.moriarty@uni.edu
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Adults aged 18-40 years.
- Apparently healthy individuals who are physically active and capable of performing vigorous exercise.
- Willing and able to complete repeated maximal-intensity cycling tests, bench press exercise, and cognitive assessments.
- Willing to consume both assigned dietary supplement formulations for 18 days each, separated by a 30-day washout period.
- Willing to refrain from taking additional creatine or electrolyte supplements during the study, including the washout period.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- History of cardiovascular, metabolic, renal, neurological, or musculoskeletal conditions that may contraindicate vigorous exercise or interfere with study outcomes.
- Current injury or physical limitation that would prevent safe completion of the exercise testing procedures.
- Current pregnancy or plans to become pregnant during the study.
- Recent creatine supplementation prior to enrollment.
- Current use of medications or dietary supplements that may interfere with creatine metabolism, hydration status, exercise performance, cognitive function, or participant safety.
- Known allergy, intolerance, or contraindication to any ingredient in the study supplements.
- Unwillingness or inability to comply with supplementation, washout, or laboratory testing requirements.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Alapvető tudomány
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Crossover kiosztás
- Maszkolás: Hármas
Fegyverek száma
Fegyverek és beavatkozások
Résztvevő csoport / karRésztvevő csoport / kar |
Beavatkozás / kezelésBeavatkozás / kezelés |
|---|---|
|
Kísérleti: Creatine Monohydrate Followed by Multi-Ingredient Creatine
Participants will receive creatine monohydrate (5 g/day) with sugar-free flavoring for 18 consecutive days, followed by a 30-day washout period. Participants will then receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period. |
Participants will consume 5 g/day of creatine monohydrate mixed with sugar-free flavoring for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period. Participants will consume a multi-ingredient dietary supplement containing creatine monohydrate (5 g), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) daily for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period. |
|
Kísérleti: Multi-Ingredient Creatine Followed by Creatine Monohydrate
Participants will receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for 18 consecutive days, followed by a 30-day washout period. Participants will then receive creatine monohydrate (5 g/day) with sugar-free flavoring for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period. |
Participants will consume 5 g/day of creatine monohydrate mixed with sugar-free flavoring for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period. Participants will consume a multi-ingredient dietary supplement containing creatine monohydrate (5 g), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) daily for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period. |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Total Bench Press Repetitions
Időkeret: Baseline and Day 18 of each supplementation period.
|
Total number of repetitions completed across three sets of bench press exercise at 70% of baseline one-repetition maximum (1RM), performed to volitional fatigue with one minute of rest between sets. |
Baseline and Day 18 of each supplementation period.
|
|
Peak Power During Repeated Wingate Tests
Időkeret: Baseline and Day 18 of each supplementation period.
|
Peak power output (watts) measured during three consecutive 30-second Wingate cycling tests, performed with standardized recovery periods. |
Baseline and Day 18 of each supplementation period.
|
|
Mean Power During Repeated Wingate Tests
Időkeret: Baseline and Day 18 of each supplementation period.
|
Mean power output (watts) measured during each of three 30-second maximal-effort Wingate cycling tests. |
Baseline and Day 18 of each supplementation period.
|
|
Total Work During Repeated Wingate Tests
Időkeret: Baseline and Day 18 of each supplementation period.
|
Total mechanical work (kilojoules) completed across three 30-second Wingate cycling tests. |
Baseline and Day 18 of each supplementation period.
|
|
Stroop Interference Reaction Time
Időkeret: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).
|
Cognitive performance assessed using a computerized Stroop task completed before exercise and during recovery between repeated Wingate tests. Reaction time (milliseconds) will be used to evaluate changes in cognitive performance as exercise-induced fatigue accumulates. |
Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).
|
|
Stroop Task Accuracy
Időkeret: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).
|
Percentage of correct responses during a computerized Stroop task administered before exercise and during recovery between repeated Wingate cycling tests. |
Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).
|
Másodlagos eredményintézkedések
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Wingate Fatigue Index
Időkeret: Baseline and Day 18 of each supplementation period.
|
Percentage decline in power output during repeated Wingate tests. |
Baseline and Day 18 of each supplementation period.
|
|
Rating of Perceived Exertion
Időkeret: Baseline and Day 18 of each supplementation period.
|
Perceived exertion assessed using the Borg 6-20 scale following each Wingate. |
Baseline and Day 18 of each supplementation period.
|
|
Blood Lactate Concentration
Időkeret: Baseline and Day 18 of each supplementation period.
|
Blood lactate concentration (mmol/L) measured following each Wingate. |
Baseline and Day 18 of each supplementation period.
|
|
Urine Specific Gravity
Időkeret: Baseline and Day 18 of each supplementation period.
|
Urine specific gravity assessed before and after exercise to evaluate hydration status. |
Baseline and Day 18 of each supplementation period.
|
|
Blood Sodium Concentration
Időkeret: Baseline and Day 18 of each supplementation period.
|
Sodium concentration measured using an i-STAT analyzer. |
Baseline and Day 18 of each supplementation period.
|
|
Blood Potassium Concentration
Időkeret: Baseline and Day 18 of each supplementation period.
|
Potassium concentration measured using an i-STAT analyzer. |
Baseline and Day 18 of each supplementation period.
|
|
Gastrointestinal Symptom Severity
Időkeret: Baseline and Day 18 of each supplementation period.
|
Daily 0-10 ratings of bloating, abdominal discomfort, nausea, diarrhea, constipation, reflux, and overall gastrointestinal discomfort. |
Baseline and Day 18 of each supplementation period.
|
Együttműködők és nyomozók
Szponzor
Szponzor
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Becsült)
Tanulmány kezdete
Elsődleges befejezés (Becsült)
Elsődleges befejezés
A tanulmány befejezése (Becsült)
A tanulmány befejezése
Tanulmányi regisztráció dátumai
Először benyújtva
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Első közzététel
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Utolsó frissítés közzétéve
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
Egyéb vizsgálati azonosító számok
- IRB-FY27-58
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .